Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
1.500
-0.060 (-3.85%)
At close: Jan 30, 2025, 4:00 PM
1.480
-0.020 (-1.32%)
After-hours: Jan 30, 2025, 6:16 PM EST
Vincerx Pharma Market Cap
Vincerx Pharma has a market cap or net worth of $2.52 million as of January 30, 2025. Its market cap has decreased by -91.41% in one year.
Market Cap
2.52M
Enterprise Value
-6.03M
1-Year Change
-91.41%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since May 27, 2020, Vincerx Pharma's market cap has decreased from $22.32M to $2.52M, a decrease of -88.72%. That is a compound annual growth rate of -37.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2025 | 2.62M | -70.32% |
| Dec 31, 2024 | 8.82M | -65.05% |
| Dec 29, 2023 | 25.23M | 16.73% |
| Dec 30, 2022 | 21.61M | -89.91% |
| Dec 31, 2021 | 214.20M | -26.75% |
| Dec 31, 2020 | 292.41M | 1,210.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.42B |
| UnitedHealth Group | 499.45B |
| Novo Nordisk | 378.98B |
| Johnson & Johnson | 362.68B |
| AbbVie | 308.91B |
| Merck & Co. | 246.92B |
| Thermo Fisher Scientific | 223.12B |
| Abbott Laboratories | 220.71B |